A little more patience. The European Parliament’s final vote, originally scheduled for March, has been postponed to late April, but the finish line is in sight. We should finally have rules that distinguish true transgenic plants (containing foreign DNA) from edited plants that do not contain extra genes and are indistinguishable from traditional breeding programs.
Continue reading
The New Genomic Techniques (NGTs) such as CRISPR are slowly rearranging the ranks in the debate on plant genetics and GM food. A few stakeholders that have always been hostile to GMOs have decided to open the door to the new opportunities coming from gene editing (in Italy, for example, the powerful farmers’ association Coldiretti has changed its mind). Others (e.g., Greenpeace, despite some isolated and courageous vanguards) have confirmed an ideological/cultural opposition, even in cases where the genetic intervention is so soft that the plants are concretely indistinguishable from those developed by conventional techniques. As for the galaxy of organic farming, it is standing still, yet something is moving. Don’t miss the article published in EUobserver by Lone Andersen and other organic farmers, who are calling on European institutions not to ban the new breeding techniques from their fields in the ongoing regulatory revision. “By encouraging the use of a limited share of the new NGTs in organic agriculture while preserving the non-GM status, the EU can further promote sustainable practices and reinforce its commitment to a greener future,” they write.
The news of the week is definitely this: the first clinical trial with base editing (the CRISPR platform used to chemically change single DNA letters without double-strand breaks) hit the goal of lowering cholesterol in patients but raised questions about the risks (with two serious adverse events, including one death), as Nature reports.
But we also recommend reading two other articles. Nature Biotechnology takes a look at experiments using CRISPR to eliminate viruses that manage to hide from the immune system, such as HIV and hepatitis. While Genetic Literacy Project publishes an analysis of the problems that could cripple the new regulation on edited plants proposed by the European Commission and delay (even until 2030) the arrival of the first products on the EU market.
The scientific community has warmly welcomed the proposal for partial deregulation of new genomic techniques put forward by the European Commission last July. Unfortunately, the legislative process will not be able to make significant progress before the next parliamentary term, which opens with the European elections in June 2024. However, this time will not be wasted if it serves to address a few problematic points and to finalise a few clarifying amendments. The devil is in the details: from the 20-nucleotide threshold proposed to delimit permissible interventions on the genome to the unknowns regarding coexistence with organic farming, not forgetting the stigma against herbicides. This article published in Nature Biotechnology by Belgian and German researchers is useful for going through the still unresolved issues.
The European Commission is collecting comments on the proposed regulation on New Genomic Techniques (NGTs) presented on 5 July. On this page you will find all the documents you need to form an opinion: from the criteria for establishing when a NGT plant is comparable to a conventional plant, to calculations on the costs of coexistence for organic producers (see in particular the Impact assessment report). The feedback received during the consultation period (8 weeks, extendable) will be summarised by the European Commission and presented to the European Parliament and the Council to feed into the legislative debate. In general, CRISPeR Frenzy appreciates the proposed regulation, especially for its focus on the promised benefits of NGTs in terms of environmental sustainability.
CRISPeR FRENZY 